Cardioprotective Effect of Electroacupuncture Pretreatment on Myocardial Ischemia/Reperfusion Injury via Antiapoptotic Signaling

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Lu, Sheng Feng ^a   Huang, Yan ^a,b   Wang, Ning ^a   Shen, Wei Xing ^a   Fu, Shu Ping ^a   Li, Qian ^a   Yu, Mei Ling ^a   Liu, Wan Xin ^c   Chen, Xia ^a   Jing, Xin Yue ^a   Zhu, Bing Mei ^a,d  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CREATINE KINASE; CREATINE KINASE MB; CYTOCHROME C; LACTATE DEHYDROGENASE; PROTEIN BCL 2; PROTEIN BCL XL; TROPONIN T; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ELECTROACUPUNCTURE; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEFT ANTERIOR DESCENDING ARTERY; MALE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

EID: 84975154658     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/4609784     Document Type: Article

References (61)

1. J. L. Anderson, H.W. Marshall, B. E. Bray et al., "A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction," The New England Journal of Medicine, vol. 308, no. 22, pp. 1312-1318, 1983.
2. A. Frank, M. Bonney, S. Bonney, L. Weitzel, M. Koeppen, and T. Eckle, "Myocardial ischemia reperfusion injury: from basic science to clinical bedside," Seminars in Cardiothoracic and Vascular Anesthesia, vol. 16, no. 3, pp. 123-132, 2012.
3. G. Ambrosio, J. L. Zweier, C. Duilio et al., "Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow," The Journal of Biological Chemistry, vol. 268, no. 25, pp. 18532-18541, 1993.
4. N. Marczin, N. El-Habashi, G. S. Hoare, R. E. Bundy, and M. Yacoub, "Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basicmechanisms," Archives of Biochemistry and Biophysics, vol. 420, no. 2, pp. 222-236, 2003.
5. D. M. Yellon and D. J. Hausenloy, "Myocardial reperfusion injury," The New England Journal of Medicine, vol. 357, no. 11, pp. 1121-1135, 2007.
6. F. Eefting, B. Rensing, J. Wigman et al., "Role of apoptosis in reperfusion injury," Cardiovascular Research, vol. 61, no. 3, pp. 414-426, 2004.
7. M. Thielmann, E. Kottenberg, P. Kleinbongard et al., "Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial," The Lancet, vol. 382, no. 9892, pp. 597-604, 2013.
8. J. S. Woo, W. Kim, S. J. Ha et al., "Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 9, pp. 2252-2260, 2013.
9. M. Chen, H. Li, and Y. Wang, "Protection by atorvastatin pretreatment in patients undergoing primary percutaneous coronary intervention is associated with the lower levels of oxygen free radicals," Journal of Cardiovascular Pharmacology, vol. 62, no. 3, pp. 320-324, 2013.
10. R. Bolli, L. Becker, G. Gross, R. Mentzer Jr., D. Balshaw, and D. A. Lathrop, "Myocardial protection at a crossroads: the need for translation into clinical therapy," Circulation Research, vol. 95, no. 2, pp. 125-134, 2004.
11. R. O. Cannon III, "Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction," Nature Clinical Practice Cardiovascular Medicine, vol. 2, no. 2, pp. 88-94, 2005.
12. F. H. Xu and J. M. Wang, "Clinical observation on acupuncture combined with medication for intractable angina pectoris," Zhongguo Zhen Jiu, vol. 25, no. 2, pp. 89-91, 2005.
13. J. Hu, "Acupuncture treatment of palpitation," Journal of Traditional Chinese Medicine, vol. 28, no. 3, pp. 228-230, 2008.
14. J. Meng, "The effects of acupuncture in treatment of coronary heart diseases," Journal of Traditional Chinese Medicine, vol. 24, no. 1, pp. 16-19, 2004.
15. J. P. Cao, "Thebasis for acupuncture treatmentof coronaryheart disease is humoral factors-mediated favorable regulation," Zhen Ci Yan Jiu, vol. 31, no. 3, pp. 185-189, 2006.
16. 2+ channel," Journal of Physiological Sciences, vol. 58, no. 6, pp. 389-396, 2008.
17. J. Li, J. Li, F. Liang et al., "Electroacupuncture at PC6 (Neiguan) improves extracellular signal-regulated kinase signaling pathways through the regulation of neuroendocrine cytokines in myocardial hypertrophic rats," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 792820, 9 pages, 2012.
18. H. L. Lujan, V. J. Kramer, and S. E. DiCarlo, "Electroacupuncture decreases the susceptibility to ventricular tachycardia in conscious rats by reducing cardiac metabolic demand," American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 5, pp. H2550-H2555, 2007.
19. X. Ni, Y. Xie, Q. Wang et al., "Cardioprotective effect of transcutaneous electric acupoint stimulation in the pediatric cardiac patients: a randomized controlled clinical trial," Paediatric Anaesthesia, vol. 22, no. 8, pp. 805-811, 2012.
20. M.-T. Tsou, C.-H. Huang, and J.-H. Chiu, "Electroacupuncture on PC6 (Neiguan) attenuates ischemia/reperfusion injury in rat hearts," American Journal of Chinese Medicine, vol. 32, no. 6, pp. 951-965, 2004.
21. S.-B. Wang, S.-P. Chen, Y.-H. Gao, M.-F. Luo, and J.-L. Liu, "Effects of electroacupuncture on cardiac and gastric activities in acute myocardial ischemia rats," World Journal of Gastroenterology, vol. 14, no. 42, pp. 6496-6502, 2008.
22. L. Yang, J. Yang, Q. Wang et al., "cardioprotective effects of electroacupuncture pretreatment on patients undergoing heart valve replacement surgery: a randomized controlled trial," Annals of Thoracic Surgery, vol. 89, no. 3, pp. 781-786, 2010.
23. H. Zhang, L. Liu, G. Huang et al., "Protective effect of electroacupuncture at the Neiguan point in a rabbit model of myocardial ischemia-reperfusion injury," Canadian Journal of Cardiology, vol. 25, no. 6, pp. 359-363, 2009.
24. Z. Jin, J. Liang, J. Wang, and P. E. Kolattukudy, "Delayed brain ischemia tolerance induced by electroacupuncture pretreatment is mediated via MCP-induced protein 1," Journal of Neuroinflammation, vol. 10, article 63, 2013.
25. J. Gao, W. Fu, Z. Jin, and X. Yu, "Acupuncture pretreatment protects heart from injury in rats with myocardial ischemia and reperfusion via inhibition of the β1-adrenoceptor signaling pathway," Life Sciences, vol. 80, no. 16, pp. 1484-1489, 2007.
26. X. Li, P. Luo, Q. Wang, and L. Xiong, "Electroacupuncture pretreatment as a novel avenue to protect brain against ischemia and reperfusion injury," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID195397, 12 pages, 2012.
27. Y. Huang, S.-F. Lu, C.-J. Hu et al., "Electro-acupuncture at Neiguan pretreatment alters genome-wide gene expressions and protects rat myocardium against ischemia-reperfusion," Molecules, vol. 19, no. 10, pp. 16158-16178, 2014.
28. Q. Wang, D. Liang, F. Wang et al., "Efficacy of electroacupuncture pretreatment for myocardial injury in patients undergoing percutaneous coronary intervention: a randomized clinical trial with a 2-year follow-up," International Journal of Cardiology, vol. 194, pp. 28-35, 2015.
29. H. S. Hwang, Y. S. Kim, Y. H. Ryu et al., "Electroacupuncture delays hypertension development through enhancing NO/NOS activity in spontaneously hypertensive rats," Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 130529, 7 pages, 2011.
30. Y. Birnbaum, Y. Ye, S. Rosanio et al., "Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemiareperfusion injury," Cardiovascular Research, vol. 65, no. 2, pp. 345-355, 2005.
31. M. J. Curtis and M. J. A. Walker, "Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia," Cardiovascular Research, vol. 22, no. 9, pp. 656-665, 1988.
32. F. Labat-Moleur, C. Guillermet, P. Lorimier et al., "TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement," Journal of Histochemistry and Cytochemistry, vol. 46, no. 3, pp. 327-334, 1998.
33. Y. Tian, W. Zhang, D. Xia, P. Modi, D. Liang, and M. Wei, "Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway," Journal of Biomedical Science, vol. 18, no. 1, article 53, 2011.
34. S.-P. Fu, S.-Y. He, B. Xu et al., "Acupuncture promotes angiogenesis after myocardial ischemia through H3K9 acetylation regulation at VEGF gene," PLoS ONE, vol. 9, no. 4, Article ID e94604, 2014.
35. Y. K. Liu, Z. J. Zhong, X. Ban, and R. S. Bonser, "A compare of three histological stain method for the diagnosis in early myocardial ischemia," Journal of Harbin Medical University, vol. 36, no. 3, pp. 238-240, 2002.
36. M. P. K. Shoobridge, "A new principle in polychrome staining: a system of automated staining, complementary to hematoxylin and eosin, and usable as a research tool," Stain Technology, vol. 58, no. 5, pp. 245-258, 1983.
37. S. Q. Liu, D. Roberts, A. Kharitonenkov et al., "Endocrine protection of ischemicmyocardiumby FGF21 fromthe liver and adipose tissue," Scientific Reports, vol. 3, article 2767, 2013.
38. J. Gao, W. Fu, Z. Jin, and X. Yu, "A preliminary study on the cardioprotection of acupuncture pretreatment in rats with ischemia and reperfusion: involvement of cardiac β-adrenoceptors," Journal of Physiological Sciences, vol. 56, no. 4, pp. 275-279, 2006.
39. W. Zhou, Y. Ko, P. Benharash et al., "Cardioprotection of electroacupuncture against myocardial ischemia-reperfusion injury bymodulation of cardiac norepinephrine release," American Journal of Physiology-Heart and Circulatory Physiology, vol. 302, no. 9, pp. H1818-H1825, 2012.
40. 2+ and connexin 43," BMC Complementary and Alternative Medicine, vol. 15, no. 1, article 5, 2015.
41. P.-Y. Liu, Y. Tian, and S.-Y. Xu, "Mediated protective effect of electroacupuncture pretreatment by miR-214 on myocardial ischemia/reperfusion injury," Journal of Geriatric Cardiology, vol. 11, no. 4, pp. 303-310, 2014.
42. V. Novack, M. Pencina, D. J. Cohen et al., "Troponin criteria formyocardial infarction after percutaneous coronary intervention," Archives of Internal Medicine, vol. 172, no. 6, pp. 502-508, 2012.
43. M. Kemp, J. Donovan, H. Higham, and J. Hooper, "Biochemical markers of myocardial injury," British Journal of Anaesthesia, vol. 93, no. 1, pp. 63-73, 2004.
44. J. Vinten-Johansen, R. Jiang, J. G. Reeves, J. Mykytenko, J. Deneve, and L. J. Jobe, "Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion injury," Hematology/Oncology Clinics of North America, vol. 21, no. 1, pp. 123-145, 2007.
45. W. Shi and J. Vinten-Johansen, "Endogenous cardioprotection by ischaemic postconditioning and remote conditioning," Cardiovascular Research, vol. 94, no. 2, pp. 206-216, 2012.
46. D. J. Hausenloy and D. M. Yellon, "Myocardial ischemiareperfusion injury: a neglected therapeutic target," The Journal of Clinical Investigation, vol. 123, no. 1, pp. 92-100, 2013.
47. A. Busca, M. Saxena, M. Kryworuchko, and A. Kumar, "Antiapoptotic genes in the survival of monocytic cells during infection," Current Genomics, vol. 10, no. 5, pp. 306-317, 2009.
48. D. S. Ziegler, A. L. Kung, and M. W. Kieran, "Anti-apoptosis mechanisms in malignant gliomas," Journal of Clinical Oncology, vol. 26, no. 3, pp. 493-500, 2008.
49. S. Fulda, "Tumor resistance to apoptosis," International Journal of Cancer, vol. 124, no. 3, pp. 511-515, 2009.
50. L. Portt, G. Norman, C. Clapp, M. Greenwood, and M.T. Greenwood, "Anti-apoptosis and cell survival: a review," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1813, no. 1, pp. 238-259, 2011.
51. S. P. Cregan, V. L. Dawson, and R. S. Slack, "Role of AIF in caspase-dependent and caspase-independent cell death," Oncogene, vol. 23, no. 16, pp. 2785-2796, 2004.
52. E. Wang, R. Marcotte, and E. Petroulakis, "Signaling pathway for apoptosis: a racetrack for life or death," Journal of Cellular Biochemistry, supplement 32-33, pp. 95-102, 1999.
53. S. Kalimuthu and K. Se-Kwon, "Cell survival and apoptosis signaling as therapeutic target for cancer: marine bioactive compounds," International Journal of Molecular Sciences, vol. 14, no. 2, pp. 2334-2354, 2013.
54. A. Vianello, V. Casolo, E. Petrussa et al., "The mitochondrial permeability transition pore (PTP)-an example of multiple molecular exaptation?" Biochimica et Biophysica Acta (BBA)- Bioenergetics, vol. 1817, no. 11, pp. 2072-2086, 2012.
55. S. Grimm and D. Brdiczka, "The permeability transition pore in cell death," Apoptosis, vol. 12, no. 5, pp. 841-855, 2007.
56. S. Shimizu, T. Kanaseki, N. Mizushima et al., "Role of Bcl-2 family proteins in a non-apoptopic programmed cell death dependent on autophagy genes," Nature Cell Biology, vol. 6, no. 12, pp. 1221-1228, 2004.
57. L. A. King, A. H. Toledo, F. A. Rivera-Chavez, and L. H. Toledo-Pereyra, "Role of p38 and JNK in liver ischemia and reperfusion," Journal of Hepato-Biliary-Pancreatic Surgery, vol. 16, no. 6, pp. 763-770, 2009.
58. L. Zhao, X. Liu, J. Liang et al., "Phosphorylation of p38 MAPK mediates hypoxic preconditioning-induced neuroprotection against cerebral ischemic injury viamitochondria translocation of Bcl-xL in mice," Brain Research, vol. 1503, pp. 78-88, 2013.
59. X.-C. Sun, X.-H. Xian, W.-B. Li et al., "Activation of p38 MAPKparticipates in brain ischemic tolerance induced by limb ischemic preconditioning by up-regulating HSP 70," Experimental Neurology, vol. 224, no. 2, pp. 347-355, 2010.
60. T. C. Zhao, G. Cheng, L. X. Zhang, Y. T. Tseng, and J. F. Padbury, "Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury," Cardiovascular Research, vol. 76, no. 3, pp. 473-481, 2007.
61. C. Bouleti, N. Mewton, and S. Germain, "The no-reflow phenomenon: state of the art," Archives of Cardiovascular Diseases, vol. 108, no. 12, pp. 661-674, 2015.